Clinical performance of nanosystem for covid-19 DNA / antibodies on-the-spot- test (NACOTS) / Munirah Zulhairee

In december 2019, the world has been shaken by a recent pandemic of highly contagious viral diseases coronavirus diseases 2019 (COVID-19). This illness has caused a global health crisis as it can transmit the virus from one person to another through droplets by symptomatic and asymptomatic patients....

Full description

Saved in:

Bibliographic Details
Main Author:	Zulhairee, Munirah
Format:	Thesis
Language:	English
Published:	2024
Subjects:	Data processing Bioinformatics
Online Access:	https://ir.uitm.edu.my/id/eprint/106829/2/106829.pdf
Tags:	Add Tag No Tags, Be the first to tag this record!

id	my-uitm-ir.106829
record_format	uketd_dc
spelling	my-uitm-ir.1068292024-12-04T07:35:07Z Clinical performance of nanosystem for covid-19 DNA / antibodies on-the-spot- test (NACOTS) / Munirah Zulhairee 2024 Zulhairee, Munirah Data processing. Bioinformatics Medical physics. Medical radiology. Nuclear medicine In december 2019, the world has been shaken by a recent pandemic of highly contagious viral diseases coronavirus diseases 2019 (COVID-19). This illness has caused a global health crisis as it can transmit the virus from one person to another through droplets by symptomatic and asymptomatic patients. The diagnostic tools in COVID-19 detection play a crucial role in curbing the spread despite the presence of vaccines and ongoing development of therapeutic drugs. The real-time Reverse Transcriptase Polymerase Chain Reaction (RT-PCR), a gold standard in detecting COVID-19 infections known as molecular diagnostic based on nucleic acid amplification test (NAAT). Even though it is high in specificity and sensitivity, RT- PCR involves a series of steps, temperature and condition, longer turnaround time (TAT) and analysis, requires skilled personnel and is high in cost. In this study, the clinical performance of Nanosystem for COVID-19 DNA/Antibodies On-The-Spot-test (NACOTS) was compared to RT-PCR to overcome the limitation of RT-PCR with shorter TAT and analysis time, portable, low cost, involves only isothermal temperature NACOTS system and high in sensitivity and specificity. The clinical performance includes the determination of clinical sensitivity, specificity, and the association between the threshold value (Ct) value of the RNA-dependent RNA polymerase (RdRp) gene by RT-PCR and positive samples of delta current I (∆I) (µA) by NACOTS. This study was conducted under the approval of the Medical Research Ethics Committee, Institute for Medical Research (IMR), Setia Alam, Selangor with 148 nasopharyngeal swab samples (N=148). The samples were subjected to both real-time RT-PCR and NACOTS. The result of the clinical sensitivity, clinical specificity and the association between both methods were validated by Student’s t-test using GraphPad Prism version 9 (GraphPad Softwares Inc). According to the result, a 95 % confidence interval (CI) was significant when the two-sided p-value was less than or equal to 0.05 (p≤0.05). The p-value of the mean difference between positive (∆I=1.283 ± 0.05) and negative (∆I=0.6285 ± 0.05) clinical samples is less than 0.0001 (p<0.0001). Whilst, the p-value of the mean difference between the clinical performance of NACOTS and RT-PCR is 0.7729 (p>0.05). The cut-off value obtained is 0.94 for NACOTS with clinical sensitivity and specificity for this study were 79 % and 85 % respectively. There was a negligible correlation between the threshold value (Ct) value of the RdRp gene and positive samples of delta current I (∆I) (µA) as the r value is 0.08. Hence, the NACOTS prototype is suitable for COVID-19 detection in limited settings like immigration detaining centres, and clinics in rural areas and applicable among tourists at the airport. 2024 Thesis https://ir.uitm.edu.my/id/eprint/106829/ https://ir.uitm.edu.my/id/eprint/106829/2/106829.pdf text en public masters Universiti Teknologi MARA (UiTM) Faculty of Applied Sciences Mohd Zain, Zainiharyati
institution	Universiti Teknologi MARA
collection	UiTM Institutional Repository
language	English
advisor	Mohd Zain, Zainiharyati
topic	Data processing Bioinformatics Data processing Bioinformatics
spellingShingle	Data processing Bioinformatics Data processing Bioinformatics Zulhairee, Munirah Clinical performance of nanosystem for covid-19 DNA / antibodies on-the-spot- test (NACOTS) / Munirah Zulhairee
description	In december 2019, the world has been shaken by a recent pandemic of highly contagious viral diseases coronavirus diseases 2019 (COVID-19). This illness has caused a global health crisis as it can transmit the virus from one person to another through droplets by symptomatic and asymptomatic patients. The diagnostic tools in COVID-19 detection play a crucial role in curbing the spread despite the presence of vaccines and ongoing development of therapeutic drugs. The real-time Reverse Transcriptase Polymerase Chain Reaction (RT-PCR), a gold standard in detecting COVID-19 infections known as molecular diagnostic based on nucleic acid amplification test (NAAT). Even though it is high in specificity and sensitivity, RT- PCR involves a series of steps, temperature and condition, longer turnaround time (TAT) and analysis, requires skilled personnel and is high in cost. In this study, the clinical performance of Nanosystem for COVID-19 DNA/Antibodies On-The-Spot-test (NACOTS) was compared to RT-PCR to overcome the limitation of RT-PCR with shorter TAT and analysis time, portable, low cost, involves only isothermal temperature NACOTS system and high in sensitivity and specificity. The clinical performance includes the determination of clinical sensitivity, specificity, and the association between the threshold value (Ct) value of the RNA-dependent RNA polymerase (RdRp) gene by RT-PCR and positive samples of delta current I (∆I) (µA) by NACOTS. This study was conducted under the approval of the Medical Research Ethics Committee, Institute for Medical Research (IMR), Setia Alam, Selangor with 148 nasopharyngeal swab samples (N=148). The samples were subjected to both real-time RT-PCR and NACOTS. The result of the clinical sensitivity, clinical specificity and the association between both methods were validated by Student’s t-test using GraphPad Prism version 9 (GraphPad Softwares Inc). According to the result, a 95 % confidence interval (CI) was significant when the two-sided p-value was less than or equal to 0.05 (p≤0.05). The p-value of the mean difference between positive (∆I=1.283 ± 0.05) and negative (∆I=0.6285 ± 0.05) clinical samples is less than 0.0001 (p<0.0001). Whilst, the p-value of the mean difference between the clinical performance of NACOTS and RT-PCR is 0.7729 (p>0.05). The cut-off value obtained is 0.94 for NACOTS with clinical sensitivity and specificity for this study were 79 % and 85 % respectively. There was a negligible correlation between the threshold value (Ct) value of the RdRp gene and positive samples of delta current I (∆I) (µA) as the r value is 0.08. Hence, the NACOTS prototype is suitable for COVID-19 detection in limited settings like immigration detaining centres, and clinics in rural areas and applicable among tourists at the airport.
format	Thesis
qualification_level	Master's degree
author	Zulhairee, Munirah
author_facet	Zulhairee, Munirah
author_sort	Zulhairee, Munirah
title	Clinical performance of nanosystem for covid-19 DNA / antibodies on-the-spot- test (NACOTS) / Munirah Zulhairee
title_short	Clinical performance of nanosystem for covid-19 DNA / antibodies on-the-spot- test (NACOTS) / Munirah Zulhairee
title_full	Clinical performance of nanosystem for covid-19 DNA / antibodies on-the-spot- test (NACOTS) / Munirah Zulhairee
title_fullStr	Clinical performance of nanosystem for covid-19 DNA / antibodies on-the-spot- test (NACOTS) / Munirah Zulhairee
title_full_unstemmed	Clinical performance of nanosystem for covid-19 DNA / antibodies on-the-spot- test (NACOTS) / Munirah Zulhairee
title_sort	clinical performance of nanosystem for covid-19 dna / antibodies on-the-spot- test (nacots) / munirah zulhairee
granting_institution	Universiti Teknologi MARA (UiTM)
granting_department	Faculty of Applied Sciences
publishDate	2024
url	https://ir.uitm.edu.my/id/eprint/106829/2/106829.pdf
_version_	1818588190756306944

Clinical performance of nanosystem for covid-19 DNA / antibodies on-the-spot- test (NACOTS) / Munirah Zulhairee

Similar Items